ISPAD Clinical Practice Consensus Guidelines 2022: Insulin treatment in children and adolescents with diabetes

Affiliations

¹ University of California San Francisco (UCSF) Pediatric Diabetes Program, UCSF School of Medicine, San Francisco, California, USA.
² Auf Der Bult, Diabetes Center for Children and Adolescents, Hannover, Germany.
³ Pediatric Endocrinology, UCSF Benioff Children's Hospital Oakland, Oakland, California, USA.
⁴ Department of Pediatrics, G. Kuppuswamy Naidu Memorial Hospital, Coimbatore, India.
⁵ Division of Tropical and Humanitarian Medicine, Faculty of Medicine University of Geneva and Geneva University Hospitals, Faculty of Medicine Diabetes Centre, Geneva, Switzerland.
⁶ Division of Pediatric Endocrinology, Mediclinic City Hospital, Dubai, UAE.
⁷ Department of Endocrinology and Diabetes, Women's and Children's Hospital, North Adelaide, Australia.
⁸ Faculty of Medical Sciences in Katowice, Medical University of Silesia, Katowice, Poland.
⁹ Paediatric Department, Southport and Ormskirk NHS Trust, Southport, UK.
¹⁰ Department of Women's and Children's Health, University of Liverpool, Liverpool, UK.
¹¹ John Hunter Children's Hospital, HRMC, New South Wales, Australia.
¹² Institute of Maternal and Child Research (IDIMI), School of Medicine, University of Chile, Santiago, Chile.

Eda Cengiz et al. Pediatr Diabetes. 2022 Dec.

. 2022 Dec;23(8):1277-1296.

doi: 10.1111/pedi.13442.

¹ University of California San Francisco (UCSF) Pediatric Diabetes Program, UCSF School of Medicine, San Francisco, California, USA.
² Auf Der Bult, Diabetes Center for Children and Adolescents, Hannover, Germany.
³ Pediatric Endocrinology, UCSF Benioff Children's Hospital Oakland, Oakland, California, USA.
⁴ Department of Pediatrics, G. Kuppuswamy Naidu Memorial Hospital, Coimbatore, India.
⁵ Division of Tropical and Humanitarian Medicine, Faculty of Medicine University of Geneva and Geneva University Hospitals, Faculty of Medicine Diabetes Centre, Geneva, Switzerland.
⁶ Division of Pediatric Endocrinology, Mediclinic City Hospital, Dubai, UAE.
⁷ Department of Endocrinology and Diabetes, Women's and Children's Hospital, North Adelaide, Australia.
⁸ Faculty of Medical Sciences in Katowice, Medical University of Silesia, Katowice, Poland.
⁹ Paediatric Department, Southport and Ormskirk NHS Trust, Southport, UK.
¹⁰ Department of Women's and Children's Health, University of Liverpool, Liverpool, UK.
¹¹ John Hunter Children's Hospital, HRMC, New South Wales, Australia.
¹² Institute of Maternal and Child Research (IDIMI), School of Medicine, University of Chile, Santiago, Chile.

No abstract available

Keywords: adolescents; children; insulin; type 1 diabetes.

References

1. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group. Clinical trial multicenter study randomized controlled trial research support, non-U.S. Gov't research support, U.S. Gov't, P.H.S. J Pediatr. 1994;125(2):177-188.
1. Schuit FC, Huypens P, Heimberg H, Pipeleers DG. Glucose sensing in pancreatic beta-cells: a model for the study of other glucose-regulated cells in gut, pancreas, and hypothalamus. Diabetes. 2001;50(1):1-11. doi:10.2337/diabetes.50.1.1
1. de Beaufort CE, Houtzagers CM, Bruining GJ, et al. Continuous subcutaneous insulin infusion (CSII) versus conventional injection therapy in newly diagnosed diabetic children: two-year follow-up of a randomized, prospective trial. Diabet Med. 1989;6(9):766-771.
1. Cengiz E, Xing D, Wong JC, et al. Severe hypoglycemia and diabetic ketoacidosis among youth with type 1 diabetes in the T1D exchange clinic registry. Pediatr Diabetes. 2013;14(6):447-454. doi:10.1111/pedi.12030
1. Arbelaez AM, Semenkovich K, Hershey T. Glycemic extremes in youth with T1DM: the structural and functional integrity of the developing brain. Pediatr Diabetes. 2013;14(8):541-553. doi:10.1111/pedi.12088